Last reviewed · How we verify

NCT07302685: TOSA

The Taiwan OSA Study

Recruiting now Last updated 24 December 2025
What this trial tests

trial in Obstructive Sleep Apnea in 7,000 participants. Currently enrolling.

Timeline
10 April 2020
Primary endpoint
28 February 2032
28 February 2032

Quick facts

Lead sponsorChina Medical University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment7,000
Start date10 April 2020
Primary completion28 February 2032
Estimated completion28 February 2032
Sites1 location across Taiwan

Conditions studied

Sponsor

China Medical University Hospital

Who can join

0 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will prospectively recruit 7000 OSA patients referred to the sleep center or China Medical University Hospital between 2020 and 2027. Polysomnographic (PSG) study data, clinical features, and health data from the National Health Insurance Research Database will be linked. Endotypic traits will be determined by PSG study parameters. The associations between clinical features, endotypic traits, and health outcome will be examined. Some patients will be invited to receive lung function tests, blood serum tests, blood gas tests, and cognitive function tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07302685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing